Targeted Therapies in Oncology
August 1 2020
Volume: 9
Issue: 1
July 1 2020
Volume: 9
Issue: 9
July 2 2020
Volume: 9
Issue: 10
June 1 2020
Volume: 9
Issue: 8
May 1 2020
Volume: 9
Issue: 5
April 2 2020
Volume: 9
Issue: 6
April 1 2020
Volume: 9
Issue: 5
March 1 2020
Volume: 9
Issue: 4
February 2 2020
Volume: 9
Issue: 3
February 1 2020
Volume: 9
Issue: 2
January 2020
Volume: 9
Issue: 1
December 2
Volume: 8
Issue: 18
December 1
Volume: 8
Issue: 17
November 2 2019
Volume: 8
Issue: 16
November 1 2019
Volume: 8
Issue: 15
October 2 2019
Volume: 8
Issue: 14
October 2019
Volume: 8
Issue: 13
September 2019
Volume: 8
Issue: 12
August 2019
Volume: 8
Issue: 11
July 2019
Volume: 8
Issue: 9
July 2
Volume: 8
Issue: 10
June 2019
Volume: 8
Issue: 8
May 2019
Volume: 8
Issue: 7
April 2 2019
Volume: 8
Issue: 6
April 2019
Volume: 8
Issue: 5
March 2019
Volume: 8
Issue: 4
February 2 2019
Volume: 8
Issue: 3
February 2019
Volume: 8
Issue: 2
January 2019
Volume: 8
Issue: 1
December 2 2018
Volume: 7
Issue: 13
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma
3
Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma
4
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
5
